DCGI approves second / third phase trial of covaxine for people aged between two and 18 years

DCGI approves second / third phase trial of covaxine for people aged between two and 18 years

DCGI approves second / third phase trial of covaxine for people aged between two and 18 years

Full size259 × 194

Leave a Reply

Your email address will not be published.